Literature DB >> 17321315

Medicalisation in the 21st century: introduction.

Jonathan M Metzl1, Rebecca M Herzig.   

Abstract

Mesh：

Year:  2007        PMID： 17321315     DOI： 10.1016/S0140-6736(07)60317-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Medicalization and overdiagnosis: different but alike.

Authors:  Bjørn Hofmann
Journal:  Med Health Care Philos       Date:  2016-06

2.  Can medicalization be good? Situating medicalization within bioethics.

Authors:  John Z Sadler; Fabrice Jotterand; Simon Craddock Lee; Stephen Inrig
Journal:  Theor Med Bioeth       Date:  2009

3.  Exploring the Intersections of Trauma, Structural Adversity, and Psychosis among a Primarily African-American Sample: A Mixed-Methods Analysis.

Authors:  Cherise Rosen; Nev Jones; Eleanor Longden; Kayla A Chase; Mona Shattell; Jennifer K Melbourne; Sarah K Keedy; Rajiv P Sharma
Journal:  Front Psychiatry       Date:  2017-04-19       Impact factor: 4.157

4.  On the biomedicalization of alcoholism.

Authors:  Ron Berghmans; Johan de Jong; Aad Tibben; Guido de Wert
Journal:  Theor Med Bioeth       Date:  2009-05-08

5.  A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.

Authors:  Opeyemi C Banjo; Roland Nadler; Peter B Reiner
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

7.  Public, health professional and legislator perspectives on the concept of psychiatric disease: a population-based survey.

Authors:  Kari A O Tikkinen; Jarno Rutanen; Allen Frances; Brea L Perry; Brittany B Dennis; Arnav Agarwal; Amna Maqbool; Shanil Ebrahim; Janne S Leinonen; Teppo L N Järvinen; Gordon H Guyatt
Journal:  BMJ Open       Date:  2019-06-04       Impact factor: 2.692

Review 8.  Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.

Authors:  Floris Alexander van de Laar
Journal:  Vasc Health Risk Manag       Date:  2008

9.  What is a disease? Perspectives of the public, health professionals and legislators.

Authors:  Kari A O Tikkinen; Janne S Leinonen; Gordon H Guyatt; Shanil Ebrahim; Teppo L N Järvinen
Journal:  BMJ Open       Date:  2012-12-02       Impact factor: 2.692

10.  Psychological drivers in doping: the life-cycle model of performance enhancement.

Authors:  Andrea Petróczi; Eugene Aidman
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.